Study Summary
This trial will compare a nasal compression device to manual compression to stop nosebleeds. Participants will evaluate their experience to see which works best.
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
1 Primary · 0 Secondary · Reporting Duration: Checked at 10 min intervals for a total of 3 intervals (30 min).
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
2 Treatment Groups
Standard of Care
1 of 2
Nasal Compression Device
1 of 2
Active Control
Experimental Treatment
40 Total Participants · 2 Treatment Groups
Primary Treatment: Nasal Compression Device · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 1 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Who else is applying?
What state do they live in?
| Texas | 100.0% |
What site did they apply to?
| Next Level Urgent Care | 100.0% |
What portion of applicants met pre-screening criteria?
| Met criteria | 100.0% |
- Traboulsi H, Alam E, Hadi U. Changing Trends in the Management of Epistaxis. Int J Otolaryngol. 2015;2015:263987. doi: 10.1155/2015/263987. Epub 2015 Aug 16.
- Bequignon E, Teissier N, Gauthier A, Brugel L, De Kermadec H, Coste A, Pruliere-Escabasse V. Emergency Department care of childhood epistaxis. Emerg Med J. 2017 Aug;34(8):543-548. doi: 10.1136/emermed-2015-205528. Epub 2016 Aug 19.
- Padgham N. Epistaxis: anatomical and clinical correlates. J Laryngol Otol. 1990 Apr;104(4):308-11. doi: 10.1017/s0022215100112563.
- Guarisco JL, Graham HD 3rd. Epistaxis in children: causes, diagnosis, and treatment. Ear Nose Throat J. 1989 Jul;68(7):522, 528-30, 532 passim.
- Gifford TO, Orlandi RR. Epistaxis. Otolaryngol Clin North Am. 2008 Jun;41(3):525-36, viii. doi: 10.1016/j.otc.2008.01.003.
- Schlosser RJ. Clinical practice. Epistaxis. N Engl J Med. 2009 Feb 19;360(8):784-9. doi: 10.1056/NEJMcp0807078. No abstract available.
- Bende M, Loth S. Vascular effects of topical oxymetazoline on human nasal mucosa. J Laryngol Otol. 1986 Mar;100(3):285-8. doi: 10.1017/s0022215100099151.
- Kucik CJ, Clenney T. Management of epistaxis. Am Fam Physician. 2005 Jan 15;71(2):305-11.
- Tunkel DE, Anne S, Payne SC, Ishman SL, Rosenfeld RM, Abramson PJ, Alikhaani JD, Benoit MM, Bercovitz RS, Brown MD, Chernobilsky B, Feldstein DA, Hackell JM, Holbrook EH, Holdsworth SM, Lin KW, Lind MM, Poetker DM, Riley CA, Schneider JS, Seidman MD, Vadlamudi V, Valdez TA, Nnacheta LC, Monjur TM. Clinical Practice Guideline: Nosebleed (Epistaxis). Otolaryngol Head Neck Surg. 2020 Jan;162(1_suppl):S1-S38. doi: 10.1177/0194599819890327.
- Doo G, Johnson DS. Oxymetazoline in the treatment of posterior epistaxis. Hawaii Med J. 1999 Aug;58(8):210-2.
- 2023. "Nasal Compression Device Study for Epistaxis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05789264.
Frequently Asked Questions
Is this research endeavor actively seeking to expand its participants?
"According to clinicaltrials.gov, this medical experimentation is currently recruiting patients and has been doing so since March 1st 2023 (most recently edited on the 15th of that same month)." - Anonymous Online Contributor
What is the current selection quota for this trial?
"Affirmative. According to clinicaltrials.gov, this trial is currently enrolling patients that meet their requirements. Initially posted on March 1st 2023 with the most recent update occurring on March 15th 2023, 40 individuals are being sought by a single medical centre." - Anonymous Online Contributor